Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%
Stopped early · Phase 2
Conditions studied: Kidney Failure, Chronic
In brief
The purpose of this study is to determine if IGIV-C, 10% will be effective in converting a donor-recipient crossmatch status from positive to negative. The crossmatch test is used to determine if the donor tissue and recipient tissue are compatible. The study will also evaluate if IGIV-C, 10% will allow successful kidney transplantation in a patient who otherwise would not be able to receive a transplant. Three dose levels of IGIV-C, 10% will be evaluated to determine what dose level is most effective.
Key facts
- Study ID
- NCT00090194
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 56
- Starts
- 2003-06-01
- Expected to finish
- 2004-03-01
- Last updated by the study team
- 2017-01-11
Who can join
Age: 1 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Children's Hospital of Alabama — Birmingham, Alabama, United States
- Banner Good Samaritan Regional Medical Center — Phoenix, Arizona, United States
- UCLA Medical Center — Los Angeles, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- University of San Francisco — San Francisco, California, United States
- Washington Hospital Center — Washington D.C., District of Columbia, United States
- University of Miami — Miami, Florida, United States
- Emory University Hospital — Atlanta, Georgia, United States
- Indiana University Medical Center — Indianapolis, Indiana, United States
- University of Massachusetts Medical Center — Worcester, Massachusetts, United States
- University of Michigan Hospitals — Ann Arbor, Michigan, United States
- University of Cincinnati — Cincinnati, Ohio, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
- University of Texas Medical Branch — Galveston, Texas, United States
- Swedish Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.